Steris (STE)

NYSE Health Care Health Care Equipment S&P 500
$252.30
-1.82 (-0.72%)
Close of Nov 06, 2026 · end-of-day data
Source: Steris's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue$2.61B$2.62B$2.78B$3.03B$3.11B$4.22B$4.54B$5.14B$5.46B$5.94B
Cost of revenue$1.59B$1.53B$1.61B$1.71B$1.76B$2.34B$2.56B$2.92B$3.06B$3.31B
Gross profit$1.03B$1.09B$1.17B$1.32B$1.34B$1.88B$1.98B$2.22B$2.40B$2.63B
Research & development$59.40M$60.78M$63.04M$65.55M$66.33M$86.66M$98.48M$103.70M$107.60M$112.90M
Selling, general & admin$682.04M$631.98M$669.94M$716.73M$731.32M$1.32B$1.09B$1.25B$1.33B$1.41B
Operating income$226.21M$399.88M$411.02M$537.05M$548.37M$477.81M$791.10M$836.10M$866.60M$1.10B
Interest expense$44.52M$50.63M$45.02M$40.28M$37.18M$89.49M$107.96M$144.35M$86.30M$60.70M
Pre-tax income$184.65M$354.98M$369.03M$498.75M$517.53M$366.80M$680.27M$702.80M$796.20M$1.05B
Income tax$74.02M$63.36M$64.28M$90.89M$120.66M$82.34M$124.07M$149.50M$184.70M$262.20M
Net income$109.97M$290.92M$303.72M$407.66M$397.40M$243.89M$107.03M$378.20M$614.60M$782.30M
EBITDA$414.35M$578.22M$636.95M$734.28M$767.61M$1.03B$1.34B$1.40B$1.34B$1.59B
EPS (basic)$1.29$3.42$3.59$4.81$4.66$2.50$1.07$3.83$6.24$7.97
EPS (diluted)$1.28$3.39$3.55$4.76$4.63$2.48$1.07$3.81$6.20$7.93
Diluted shares86.09M85.71M85.47M85.64M85.90M98.33M100.25M99.40M99.10M98.70M
Gross margin39.3%41.7%42.2%43.6%43.2%44.6%43.7%43.2%44.0%44.2%
Operating margin8.7%15.3%14.8%17.7%17.6%11.3%17.4%16.3%15.9%18.6%
Net margin4.2%11.1%10.9%13.5%12.8%5.8%2.4%7.4%11.3%13.2%

Balance sheet

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash & equivalents$282.92M$201.53M$220.63M$319.58M$220.53M$348.32M$208.36M$207.02M$171.70M$439.60M
Receivables—$528.07M$564.83M$586.48M$609.41M$799.04M$864.99M$1.01B$1.04B$1.09B
Inventory—$205.73M$208.24M$263.54M$315.07M$575.00M$604.41M$674.53M$581.30M$631.80M
Total current assets—$989.66M$1.05B$1.22B$1.21B$1.88B$2.01B$2.87B$2.00B$2.39B
Goodwill$2.23B$2.43B$2.32B$2.36B$3.03B$3.94B$3.88B$4.07B$4.10B$4.19B
Total assets—$5.20B$5.07B$5.44B$6.57B$11.42B$10.82B$11.06B$10.15B$10.74B
Total current liabilities—$398.46M$465.20M$503.61M$577.92M$922.22M$861.84M$931.13M$1.02B$1.15B
Short-term debt———$0$0$142.88M$60.00M$85.94M$125.00M$118.90M
Long-term debt—$1.32B$1.18B$1.15B$1.65B$2.95B$3.02B$3.12B$1.92B$1.81B
Total debt—$1.32B$1.18B$1.15B$1.65B$3.09B$3.08B$3.21B$2.04B$1.93B
Total liabilities—$1.98B$1.89B$2.02B$2.68B$4.88B$4.73B$4.75B$3.53B$3.54B
Shareholders' equity$2.81B$3.21B$3.18B$3.41B$3.88B$6.53B$6.08B$6.30B$6.60B$7.18B

Cash flow

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow$424.09M$457.63M$539.50M$590.56M$689.64M$684.81M$756.95M$973.30M$1.15B$1.34B
Capital expenditures$172.90M$165.46M$189.72M$214.52M$239.26M$287.56M$361.97M$360.30M$370.10M$369.00M
Free cash flow$251.19M$292.18M$349.79M$376.04M$450.38M$397.25M$394.98M$613.00M$778.00M$972.40M
Investing cash flow-$104.25M-$203.83M-$213.22M-$319.74M-$1.15B-$666.56M-$383.33M-$887.40M$388.80M-$512.50M
Financing cash flow-$267.10M-$356.18M-$294.79M-$163.15M$345.62M$115.83M-$498.72M-$85.20M-$1.57B-$568.20M
Dividends paid$93.19M$102.93M$112.50M$123.03M$133.84M$163.17M$183.50M$200.60M$219.90M$241.80M
Share buybacks$97.51M$65.48M$81.49M$51.24M$14.65M$55.78M$308.56M$11.80M$211.30M$235.50M
Stock-based compensation$18.79M$22.19M$23.96M$23.81M$25.97M$57.66M$38.95M$56.50M$57.40M$61.70M
Depreciation & amortization$188.14M$178.33M$225.92M$197.24M$219.24M$553.10M$552.90M$565.20M$476.20M$486.50M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.